Cite
HARVARD Citation
Hellmann, M. et al. (2020). Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer. International journal of cancer. 147 (7), pp. 1963-1969. [Online].